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Several talks focused on technologies allowing for enhanced analysis of cancer cells. For example, Mark Shaaya (Andrei Karginov lab, University of Illinois at Chicago) engineered a light-regulated allosteric switch based on a small domain from a photoreceptor that undergoes conformational changes upon illumination with blue light. Insertion into the catalytic domain of Src kinase enabled lightmediated control of Src activity, allowing for the transient and local activation of this critical signaling kinase in living cells. Benjamin Martin (Stony Brook University) discussed a collaborative project between his lab and the labs of David Matus and Eric Betzig. They used adaptive optics light sheet imaging in a zebrafish xenograft model to capture high-resolution time-lapse movies of the behavior of circulating human tumor cells. The amazing movies presented support a model in which circulating tumor cells co-opt mechanisms used by leukocytes during the process of extravasation (movement from the capillaries into the surrounding tissue). David Dingal (Lei Qi lab, Stanford University) presented a novel technology called CRISPR ChaCha that couples programmable CRISPR-Cas9 with the ligand-sensing ability of diverse G protein-coupled receptors. CRISPR ChaCha improves upon earlier assays by using CRISPRbased effectors that target endogenous genes in the genome, and by showing through modeling and experiments that it is a "one receptor in, multiple effectors out" system.
Other talks focused more on the spatial and temporal regulation of signaling in cancer cells. Debanjan Goswami (Frederick National Laboratory for Cancer Research) used single-molecule tracking to reveal that KRAS4b, a major regulator of proliferation in cancer cells, diffuses in three distinct mobility states in the plasma membrane. These states compartmentalize KRAS in the membrane and orchestrate a spatiotemporal control of effector interactions based on diffusion modality. Mariam Beshay (Chris Janetopoulos lab, University of the Sciences in Philadelphia) demonstrated how the plasma membrane levels of PI(4,5)P 2 are critical for altering cell migration and morphology, with lower levels contributing to active signaling networks and cell protrusions at the leading edge, while elevated levels result in actomyosin contraction at the rear or uropod of the cell. Matthew Lee (Llyod Trotman lab, Cold Spring Harbor Laboratory) showed that PTEN, a negative regulator of PI 3-K signaling, can bind the signature lipid of early endosomes, PI(3)P, to productively act on the secondary messenger PIP3. Matthew Lee's results introduced us to a series of novel upstream activators of PTEN, one of which is the endocytic protein clathrin. Peter McPherson (McGill University) continued on the theme of membrane trafficking, discussing DENN domain proteins, which function as activators of Rab GTPases, critical regulators of membrane trafficking. Using multiple tools including a single-chain FRET biosensor designed to measure the localized activation of Rabs in living cells, he described how alterations in membrane trafficking pathways contribute to alterations in cell behavior that contribute to growth and metastasis of cancer cells.
Timing and duration of signaling were recurring themes of the session. Jeremiah Keyes (Jin Zhang lab, University of California, San Diego) reported improved FRET-based ERK biosensors that are targeted to various subcellular regions. He demonstrated differential duration of ERK activation between the plasma membrane and the cytosol in response to EGF stimulation. The plasma membranelocalized ERK signaling appears to be necessary for normal cell morphology and adhesion. Min Wu (National University of Singapore) demonstrated that the level of PI3-kinase activation is frequency encoded by the cortical oscillatory traveling waves made of F-BAR protein FBP17, active Cdc42, and actin. In mitotic cells these cortical waves propagate as concentric target patterns and their frequencies encode size information that is used to ensure the singularity of cell division. Kshitiz (Andre Levchenko lab, Yale University) used fluorescent reporters to visualize the activity of hypoxia-inducible factor-1 alpha (HIF-1α) as a measure of cellular response to hypoxia in cancer cells. These studies revealed oscillations in HIF-1α activity that may help cancer cells cheat and overcome hypoxia-mediated inhibition of cell division. This mechanism provides an answer to the longstanding conundrum as to why tumor cells continue to proliferate in hypoxic conditions.
Together, the talks in this exciting and highly visual session highlighted the importance of understanding the spatial and temporal regulation of signaling toward a comprehensive understanding of cancer cell biology. 
